突发性听力损失对AAO-HNSF临床实践指南的依从性分析
回顾性队列研究利用TriNetX数据库评估2019年AAO-HNSF突发性听力损失指南依从性:24,203例突发性听力损失患者中59.1%接受推荐听力图检查,仅35.8%在2周内完成;3,107例单侧突发性感音神经性听力损失中25.5%在1个月内完成MRI或听性脑干反应检查,3.5%诊断前庭神经鞘瘤,54.5%接受类固醇治疗,<0.3%接受高压氧。
要点
- 59.1%的突发性听力损失患者接受了推荐听力图检查,35.8%在2周内完成。
- 单侧突发性感音神经性听力损失患者中仅25.5%在1个月内完成MRI或听性脑干反应检查。
- 54.5%的单侧突发性感音神经性听力损失患者接受类固醇治疗,<0.3%接受高压氧。
核心结论
- 突发性听力损失尤其是突发性感音神经性听力损失患者的评估存在显著改善机会,恰当遵循指南可能改善神经耳科病变包括前庭神经鞘瘤的筛查、检测和管理。
研究设计与样本
- 回顾性队列研究,数据来源于TriNetX去标识化医疗数据库,共纳入24,203例突发性听力损失患者。
主要发现
- 24,203例突发性听力损失患者中59.1%(n=14,309)接受了推荐听力图检查,35.8%(n=8,674)在2周内完成。
- 3,107例诊断为单侧突发性感音神经性听力损失,104例为单侧传导性听力损失,121例为混合性听力损失,10,977例失访。
- 3,107例单侧突发性感音神经性听力损失中仅25.5%(n=791)在1个月内完成MRI或听性脑干反应检查,3.5%(n=28)诊断前庭神经鞘瘤。
- 单侧突发性感音神经性听力损失患者中54.5%(n=1,692)接受类固醇治疗,<0.3%(n≤10)接受高压氧治疗。
- 2.0%(n=63)接受CT扫描,<0.3%(n≤10)接受血管扩张剂或溶栓药物,3.5%(n=108)接受抗病毒药物。
关键数值与推荐
- 指南推荐突发性听力损失患者应在2周内完成听力图检查以区分突发性感音神经性听力损失与传导性听力损失。
- 指南推荐突发性感音神经性听力损失患者应行MRI或听性脑干反应检查,并可在2周内提供类固醇和/或高压氧治疗。
- 指南强烈推荐反对或证据不足以下诊断和治疗:CT扫描、血管扩张剂或溶栓药物、抗病毒药物。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To assess adherence to the 2019 American Academy of Otolaryngology-Head and Neck Surgery (AAO-HNSF) guidelines for the diagnosis and management of sudden hearing loss (SHL) and sudden sensorineural hearing loss (SSNHL). STUDY DESIGN: Retrospective cohort. SETTING: TriNetX, a de-identified healthcare database. METHODS: Evaluation focused on the percentage of patients undergoing proper guideline-adherent workup and treatment for SHL. Key measures include audiogram testing within 2 weeks for distinguishing SSNHL from CHL. For SSNHL patients, MRI or auditory brainstem response (ABR) testing should be obtained, and steroids and/or hyperbaric oxygen may be offered within 2 weeks. RESULTS: There were 24,203 SHL patients, 59.1% (n = 14,309) of whom underwent recommended audiogram testing, with 35.8% (n = 8,674) completing it within 2 weeks. Overall, 3,107 were diagnosed with unilateral SSNHL, 104 with unilateral conductive hearing loss (CHL), 121 with mixed hearing loss, and 10,977 were lost to follow-up. Among 3,107 SSNHL cases, just 25.5% (n = 791) obtained MRI/ABR within 1 month, and vestibular schwannoma was diagnosed in 3.5% (n = 28). Additionally, steroids were prescribed to 54.5% (n = 1,692), and <0.3% (n ≤ 10) received hyperbaric oxygen. In accordance with strong recommendations against or insufficient evidence to support the following diagnostics and treatments, 2.0% (n = 63) underwent a CT scan, less than 0.3% (n ≤ 10) were prescribed vasodilators or thrombolytics, and 3.5% (n = 108) were on antivirals. CONCLUSION: There is a significant opportunity for improvement in evaluating patients with SHL, specifically SSNHL. Proper adherence to guidelines may improve screening, detection, and management of neurotologic pathologies, including vestibular schwannoma.
引用
- Sciscent BY, Lorenz FJ, Eberly HW, et al. Analysis of Adherence to AAO-HNSF Clinical Practice Guidelines for Sudden Hearing Loss. Otolaryngol Head Neck Surg. 2024. PMID: 39501672. doi:10.1002/ohn.1050
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。